Moderna (Indonesian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Moderna" in Indonesian language version.

refsWebsite

Global rank Indonesian rank

16web.archive.org

1^st place

4statnews.com

8,771^st place

low place

3doi.org

2^nd place

4^th place

3xconomy.com

low place

3modernatx.com

low place

2sec.gov

572^nd place

529^th place

2nih.gov

4^th place

13^th place

2cnn.com

28^th place

70^th place

1pbs.org

198^th place

417^th place

1archive.today

14^th place

30^th place

1globalnews.ca

985^th place

6,809^th place

1bizjournals.com

407^th place

1,557^th place

1youtube.com

9^th place

21^st place

1bioworld.com

low place

1sciencemag.org

857^th place

574^th place

1bostonmagazine.com

3,842^nd place

low place

1nytimes.com

7^th place

35^th place

1bostonglobe.com

553^rd place

2,906^th place

1pharmaceutical-technology.com

low place

1boston.com

310^th place

1,233^rd place

1reuters.com

49^th place

96^th place

archive.today

"Moderna chairman: We don't need deep-freeze conditions for vaccine". CNN. November 16, 2020. Diarsipkan dari versi asli tanggal December 4, 2020.

bioworld.com

Shaffer, Catherine (December 6, 2013). "Moderna Makes Entrance with $40M Round for mRNA Work". BioWorld. Diarsipkan dari versi asli tanggal November 16, 2020.

bizjournals.com

Alspach, Kyle (May 22, 2013). "Moderna CEO Bancel joins Flagship Ventures as senior partner". American City Business Journals. Diarsipkan dari versi asli tanggal January 31, 2014.

boston.com

Reidy, Chris (January 13, 2014). "Alexion, Moderna announce agreement to develop messenger RNA therapeutics". The Boston Globe. Diarsipkan dari versi asli tanggal November 16, 2020.

bostonglobe.com

Weisman, Robert (March 21, 2013). "Moderna in line for $240m licensing deal". The Boston Globe. Diarsipkan dari versi asli tanggal November 16, 2020.

bostonmagazine.com

Elton, Catherine (March 2013). "The NEXT Next Big Thing". Boston Magazine. Diarsipkan dari versi asli tanggal November 16, 2020.

cnn.com

edition.cnn.com

"Moderna chairman: We don't need deep-freeze conditions for vaccine". CNN. November 16, 2020. Diarsipkan dari versi asli tanggal December 4, 2020.

cnn.com

Cohen, Elizabeth (November 30, 2020). "Moderna applies for FDA authorization for its Covid-19 vaccine". CNN.

doi.org

Servick, Kelly (February 1, 2017). "This mysterious $2 billion biotech is revealing the secrets behind its new drugs and vaccines". Science. doi:10.1126/science.aal0686. Diarsipkan dari versi asli tanggal November 16, 2020.
Zangi, Lior; Lui, Kathy O.; von Gise, Alexander; Ma, Qing; Ebina, Wataru; Ptaszek, Leon M.; Später, Daniela; Xu, Huansheng; Tabebordbar, Mohammadsharif; Gorbatov, Rostic; Sena, Brena; Nahrendorf, Matthias; Briscoe, David M.; Li, Ronald A.; Wagers, Amy J.; Rossi, Derrick J.; Pu, William T.; Chien, Kenneth R. (September 8, 2013). "Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction". Nature Biotechnology. 31 (10): 898–907. doi:10.1038/nbt.2682. PMC 4058317 . PMID 24013197.
Sedic M, Senn JJ, Lynn A, Laska M, Smith M, Platz SJ, Bolen J, Hoge S, Bulychev A, Jacquinet E, Bartlett V, Smith PF (March 2018). "Safety Evaluation of Lipid Nanoparticle-Formulated Modified mRNA in the Sprague-Dawley Rat and Cynomolgus Monkey". Vet Pathol. 55 (2): 341–354. doi:10.1177/0300985817738095. PMID 29191134.

globalnews.ca

"Christmas comes early as first Moderna vaccines arrive in Canada". Global News. December 24, 2020.

modernatx.com

"Key Facts". Moderna.
"Our Pipeline". Moderna. Diarsipkan dari versi asli tanggal November 16, 2020. Diakses tanggal May 19, 2020.

investors.modernatx.com

"DARPA Awards Moderna Therapeutics a Grant for up to $25 Million to Develop Messenger RNA Therapeutics". 2 October 2013. Diarsipkan dari versi asli tanggal 2021-07-07. Diakses tanggal 2021-07-08.

nih.gov

ncbi.nlm.nih.gov

Zangi, Lior; Lui, Kathy O.; von Gise, Alexander; Ma, Qing; Ebina, Wataru; Ptaszek, Leon M.; Später, Daniela; Xu, Huansheng; Tabebordbar, Mohammadsharif; Gorbatov, Rostic; Sena, Brena; Nahrendorf, Matthias; Briscoe, David M.; Li, Ronald A.; Wagers, Amy J.; Rossi, Derrick J.; Pu, William T.; Chien, Kenneth R. (September 8, 2013). "Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction". Nature Biotechnology. 31 (10): 898–907. doi:10.1038/nbt.2682. PMC 4058317 . PMID 24013197.
Sedic M, Senn JJ, Lynn A, Laska M, Smith M, Platz SJ, Bolen J, Hoge S, Bulychev A, Jacquinet E, Bartlett V, Smith PF (March 2018). "Safety Evaluation of Lipid Nanoparticle-Formulated Modified mRNA in the Sprague-Dawley Rat and Cynomolgus Monkey". Vet Pathol. 55 (2): 341–354. doi:10.1177/0300985817738095. PMID 29191134.

nytimes.com

Pollack, Andrew (March 21, 2013). "AstraZeneca Makes a Bet on an Untested Technique". The New York Times. Diarsipkan dari versi asli tanggal November 16, 2020.

pbs.org

"What we know about Moderna's COVID-19 vaccine candidate—and what we don't". PBS News Hour. November 16, 2020. Diarsipkan dari versi asli tanggal December 4, 2020. Noubar Afeyan is a co-founder and chairman of Moderna...

pharmaceutical-technology.com

"Moderna's gamble: what's behind biotech's biggest-ever IPO?". Pharmaceutical Technology. February 21, 2019. Diarsipkan dari versi asli tanggal November 16, 2020. Diakses tanggal May 20, 2020.

reuters.com

"With Wuhan virus genetic code in hand, scientists begin work on a vaccine". Reuters (dalam bahasa Inggris). 2020-01-24. Diakses tanggal 2020-01-26.

sciencemag.org

Servick, Kelly (February 1, 2017). "This mysterious $2 billion biotech is revealing the secrets behind its new drugs and vaccines". Science. doi:10.1126/science.aal0686. Diarsipkan dari versi asli tanggal November 16, 2020.

sec.gov

statnews.com

Garade, Damien (September 13, 2016). "Ego, ambition, and turmoil: Inside one of biotech's most secretive startups". Stat. Diarsipkan dari versi asli tanggal November 16, 2020.
Garde, Damien (January 10, 2017). "Lavishly funded Moderna hits safety problems in bold bid to revolutionize medicine". Stat. Diarsipkan dari versi asli tanggal November 16, 2020.
"The story of mRNA: From a loose idea to a tool that may help curb Covid". STAT. November 10, 2020.
Garde, Damian; Saltzman, Jonathan (November 10, 2020). "The story of mRNA: How a once-dismissed idea became a leading technology in the Covid vaccine race". STAT. Diarsipkan dari versi asli tanggal November 10, 2020.

web.archive.org

"What we know about Moderna's COVID-19 vaccine candidate—and what we don't". PBS News Hour. November 16, 2020. Diarsipkan dari versi asli tanggal December 4, 2020. Noubar Afeyan is a co-founder and chairman of Moderna...
Alspach, Kyle (May 22, 2013). "Moderna CEO Bancel joins Flagship Ventures as senior partner". American City Business Journals. Diarsipkan dari versi asli tanggal January 31, 2014.
Shaffer, Catherine (December 6, 2013). "Moderna Makes Entrance with $40M Round for mRNA Work". BioWorld. Diarsipkan dari versi asli tanggal November 16, 2020.
Garade, Damien (September 13, 2016). "Ego, ambition, and turmoil: Inside one of biotech's most secretive startups". Stat. Diarsipkan dari versi asli tanggal November 16, 2020.
Garde, Damien (January 10, 2017). "Lavishly funded Moderna hits safety problems in bold bid to revolutionize medicine". Stat. Diarsipkan dari versi asli tanggal November 16, 2020.
Servick, Kelly (February 1, 2017). "This mysterious $2 billion biotech is revealing the secrets behind its new drugs and vaccines". Science. doi:10.1126/science.aal0686. Diarsipkan dari versi asli tanggal November 16, 2020.
Kutz, Erin (October 4, 2010). "ModeRNA, Stealth Startup Backed By Flagship, Unveils New Way to Make Stem Cells". Xconomy. Diarsipkan dari versi asli tanggal February 8, 2017.
Huang, Gregory (December 6, 2012). "Moderna, $40M in Tow, Hopes to Reinvent Biotech with "Make Your Own Drug"". Xconomy. Diarsipkan dari versi asli tanggal November 22, 2018.
Elton, Catherine (March 2013). "The NEXT Next Big Thing". Boston Magazine. Diarsipkan dari versi asli tanggal November 16, 2020.
Garde, Damian; Saltzman, Jonathan (November 10, 2020). "The story of mRNA: How a once-dismissed idea became a leading technology in the Covid vaccine race". STAT. Diarsipkan dari versi asli tanggal November 10, 2020.
Pollack, Andrew (March 21, 2013). "AstraZeneca Makes a Bet on an Untested Technique". The New York Times. Diarsipkan dari versi asli tanggal November 16, 2020.
Weisman, Robert (March 21, 2013). "Moderna in line for $240m licensing deal". The Boston Globe. Diarsipkan dari versi asli tanggal November 16, 2020.
"Moderna's gamble: what's behind biotech's biggest-ever IPO?". Pharmaceutical Technology. February 21, 2019. Diarsipkan dari versi asli tanggal November 16, 2020. Diakses tanggal May 20, 2020.
"Our Pipeline". Moderna. Diarsipkan dari versi asli tanggal November 16, 2020. Diakses tanggal May 19, 2020.
"DARPA Awards Moderna Therapeutics a Grant for up to $25 Million to Develop Messenger RNA Therapeutics". 2 October 2013. Diarsipkan dari versi asli tanggal 2021-07-07. Diakses tanggal 2021-07-08.
Reidy, Chris (January 13, 2014). "Alexion, Moderna announce agreement to develop messenger RNA therapeutics". The Boston Globe. Diarsipkan dari versi asli tanggal November 16, 2020.

xconomy.com

Kutz, Erin (October 4, 2010). "ModeRNA, Stealth Startup Backed By Flagship, Unveils New Way to Make Stem Cells". Xconomy. Diarsipkan dari versi asli tanggal February 8, 2017.
Huang, Gregory (December 6, 2012). "Moderna, $40M in Tow, Hopes to Reinvent Biotech with "Make Your Own Drug"". Xconomy. Diarsipkan dari versi asli tanggal November 22, 2018.
Timmerman, Luke (20 November 2013). "Moderna Vacuums Up Another $110M to Make Messenger RNA Drugs". Xconomy.

youtube.com

Moderna (October 23, 2019). mRNA-3704 and Methylmalonic Acidemia (Video) – via YouTube.